These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23256810)

  • 21. Opening the lead generation toolbox.
    Simpson PB; Reichman M
    Nat Rev Drug Discov; 2014 Jan; 13(1):3-4. PubMed ID: 24378783
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID has shown the power of science-industry collaboration.
    Nature; 2021 Jun; 594(7863):302. PubMed ID: 34135530
    [No Abstract]   [Full Text] [Related]  

  • 23. Academia-industry collaboration: an integral element for building "omic" resources.
    Hill DE; Brasch MA; del Campo AA; Doucette-Stamm L; Garrels JI; Glaven J; Hartley JL; Hudson JR; Moore T; Vidal M
    Genome Res; 2004 Oct; 14(10B):2010-4. PubMed ID: 15489319
    [No Abstract]   [Full Text] [Related]  

  • 24. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
    Kamel N; Compton C; Middelveld R; Higenbottam T; Dahlén SE
    Eur Respir J; 2008 May; 31(5):924-6. PubMed ID: 18448501
    [No Abstract]   [Full Text] [Related]  

  • 26. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
    Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
    Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of academic institutions in the development of drugs for rare and neglected diseases.
    Coles LD; Cloyd JC
    Clin Pharmacol Ther; 2012 Aug; 92(2):193-202. PubMed ID: 22760003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newsmaker interview. Genentech scientist to take the helm at Rockefeller University. Interview by Greg Miller.
    Tessier-Lavigne M
    Science; 2010 Sep; 329(5998):1456. PubMed ID: 20847242
    [No Abstract]   [Full Text] [Related]  

  • 29. Bringing together the academic drug discovery community.
    Slusher BS; Conn PJ; Frye S; Glicksman M; Arkin M
    Nat Rev Drug Discov; 2013 Nov; 12(11):811-2. PubMed ID: 24172316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Academia-industry dialogue: a step toward mutual understanding.
    Becker RE
    Circulation; 1985 Aug; 72(2 Pt 2):I53-6. PubMed ID: 4006161
    [No Abstract]   [Full Text] [Related]  

  • 31. Academia-industry alliance: Belfer Institute and sanofi-aventis collaborate to develop new cancer therapeutics.
    Dis Model Mech; 2010; 3(11-12):669. PubMed ID: 21030419
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic monoclonal antibodies in the French community: let's get organized].
    Watiez D; Watier H
    Med Sci (Paris); 2009 Dec; 25(12):1189-92. PubMed ID: 20035704
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
    Kaski JC
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
    [No Abstract]   [Full Text] [Related]  

  • 34. Academia and industry: Companies on campus.
    Watson-Capps JJ; Cech TR
    Nature; 2014 Oct; 514(7522):297-8. PubMed ID: 25318508
    [No Abstract]   [Full Text] [Related]  

  • 35. A renaissance in biomedical innovation: global villages raise effective therapies.
    Collyar D; Chaguturu R
    Future Med Chem; 2015; 7(8):971-4. PubMed ID: 26062394
    [No Abstract]   [Full Text] [Related]  

  • 36. Industry and academia in collaboration: the Pfizer experience.
    Price FD
    Circulation; 1985 Aug; 72(2 Pt 2):I13-7. PubMed ID: 4006152
    [No Abstract]   [Full Text] [Related]  

  • 37. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 38. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug discovery. New institute aims to help academics make medicines.
    Service RF
    Science; 2012 Mar; 335(6074):1288-9. PubMed ID: 22422951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.